Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial

{{article.zuoZheEn}}

PDF(2181 KB)
PDF(2181 KB)
Life Metabolism ›› 2023, Vol. 2 ›› Issue (3) : 139-148. DOI: 10.1093/lifemeta/load019
Clinical and Translational Study

Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Life Metabolism, 2023, 2(3): 139‒148 https://doi.org/10.1093/lifemeta/load019

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(2181 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉